Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Need for Harmonization

被引：3
|
作者：
Crowley, Eileen [1 ,2 ]
Griffiths, Anne M. [3 ]
Jairath, Vipul [2 ,4 ,5 ]
机构：
[1] Western Univ, London Hlth Sci Ctr, Childrens Hosp Western Ontario, Div Pediat Gastroenterol,Dept Pediat, London, ON, Canada
[2] Alimentiv Inc, London, ON, Canada
[3] Univ Toronto, SickKids Hosp, Div Gastroenterol Hepatol & Nutr, Dept Pediat,IBD Ctr, Toronto, ON, Canada
[4] Western Univ, London Hlth Sci Ctr, Dept Med, Div Gastroenterol, London, ON, Canada
[5] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
来源：
GASTROENTEROLOGY | 2022年 / 163卷 / 05期
关键词：
ULCERATIVE-COLITIS; VALIDATION; PLACEBO;
D O I：
10.1053/j.gastro.2022.07.006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1137 / 1144
页数：8
相关论文
共 50 条
  • [1] Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review
    Ma, Christopher
    Hussein, Isra M.
    Al-Abbar, Yousef J.
    Panaccione, Remo
    Fedorak, Richard N.
    Parker, Claire E.
    Nguyen, Tran M.
    Khanna, Reena
    Siegel, Corey A.
    Peyrin-Biroulet, Laurent
    Pai, Rish K.
    Vande Casteele, Niels
    D'Haens, Geert R.
    Sandborn, William J.
    Feagan, Brian G.
    Jairath, Vipul
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (09) : 1407 - +
  • [2] Efficient Estimation of the Efficacy and Safety Endpoints for Clinical Trials with Preplanned Dose Titrations
    Qu, Yongming
    Cui, Xuewei
    Bray, Ross
    Sun, Nicholas
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (01): : 214 - 224
  • [3] Efficacy Endpoints in Clinical Trials in Actinic Keratosis
    Skov, Torsten
    Stockfleth, Eggert
    Szeimies, Rolf-Markus
    Berman, Brian
    [J]. DERMATOLOGY AND THERAPY, 2018, 8 (03) : 425 - 433
  • [4] Efficacy Endpoints in Clinical Trials in Actinic Keratosis
    Torsten Skov
    Eggert Stockfleth
    Rolf-Markus Szeimies
    Brian Berman
    [J]. Dermatology and Therapy, 2018, 8 : 425 - 433
  • [5] Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA
    Green, Dionna J.
    Burnham, Janelle M.
    Schuette, Paul
    Liu, Xiaomei I.
    Maas, Brian M.
    Yao, Lynne
    McCune, Susan K.
    Chen, Joseph
    van den Anker, John N.
    Burckart, Gilbert J.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07): : 885 - 890
  • [6] Interpreting tests for efficacy in clinical trials with multiple endpoints
    OBrien, PC
    Geller, NL
    [J]. CONTROLLED CLINICAL TRIALS, 1997, 18 (03): : 222 - 227
  • [7] Clinical Relevance of Efficacy Endpoints in OTC Headache Trials
    Pageler, Lutz
    Diener, Hans-Christoph
    Pfaffenrath, Volker
    Peil, Hubertus
    Aicher, Bernhard
    [J]. HEADACHE, 2009, 49 (05): : 646 - 654
  • [8] Endpoints in clinical trials on transfusion requirements: the need for a structured approach
    Hardy, JF
    [J]. TRANSFUSION, 2005, 45 (01) : 9S - 13S
  • [9] Efficacy and safety in clinical trials
    Cohn, Jay N.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) : 729 - 729
  • [10] Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials
    Watanabe, Shinya
    Nonaka, Takahiro
    Maeda, Makoto
    Sugii, Narushi
    Hashimoto, Koichi
    Takano, Shingo
    Koyanagi, Tomoyoshi
    Yamada, Masanobu
    Arakawa, Yoshihiro
    Ishikawa, Eiichi
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 603 - 610
12345